Tempest Therapeutics, Inc. (TPST) Ownership

$0.95

south_east
-$0 (-0.28%)
Day's range
$0.93
Day's range
$1.05

Tempest Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VERSANT VENTURE MANAGEMENT, LLC 02/12/2025 3.51 M $2.93 M   100.00% 13.59%
BLACKROCK FUNDING, INC. /DE 02/07/2025 551,861 $460,528   0.05% 2.14%
JANE STREET GROUP, LLC 02/14/2025 493,094 $411,487   100.00% 1.91%
FMR LLC 02/13/2025 431,932 $360,447   0.00% 1.67%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 354,276 $295,662   60.99% 1.37%
UBS GROUP AG 02/14/2025 195,676 $163,390   2,230.86% 0.76%
MILLENNIUM MANAGEMENT LLC 02/14/2025 189,506 $158,143   100.00% 0.73%
VANGUARD GROUP INC 02/11/2025 176,193 $147,121   0.00% 0.68%
XTX TOPCO LTD 02/13/2025 160,807 $134,193   570.34% 0.62%
FIL LTD 02/13/2025 129,579 $108,134   0.00% 0.50%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 123,422 $102,996   172.70% 0.48%
IKARIAN CAPITAL, LLC 02/14/2025 105,285 $87,860   -0.30% 0.41%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 84,300 $69,969   54.11% 0.33%
DAVENPORT & CO LLC 01/24/2025 50,000 $41,725   0.00% 0.19%
VIRTU FINANCIAL LLC 02/11/2025 43,105 $36,000   100.00% 0.17%
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 25,378 $35,520   0.00% 0.10%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 24,257 $20,242   -1.28% 0.09%
ENGINEERS GATE MANAGER LP 02/14/2025 23,496 $19,607   100.00% 0.09%
SIMPLEX TRADING, LLC 02/11/2025 18,913 $15,000   44.63% 0.07%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 10,918 $9,117   80.97% 0.04%
NATIONAL BANK OF CANADA /FI/ 02/12/2025 10,000 $8,350   100.00% 0.04%
MAYTECH GLOBAL INVESTMENTS, LLC 02/14/2025 10,000 $8,345   0.00% 0.04%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 02/14/2025 3,800 $3,173   100.00% 0.01%
CITIGROUP INC 02/12/2025 972 $811   100.00% 0.00%
02/11/2025 800 $668   100.00% 0.00%
02/06/2025 767 $640   100.00% 0.00%
PARALLEL ADVISORS, LLC 02/10/2025 235 $197   0.00% 0.00%
01/23/2025 190 $159   100.00% 0.00%
CIBC PRIVATE WEALTH GROUP, LLC 02/12/2025 133 $131   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 48 $40   100.00% 0.00%
GLOBAL RETIREMENT PARTNERS, LLC 01/31/2025 5 $4   100.00% 0.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 02/10/2025 0 $0   -100.00% 0.00%
TWO SIGMA INVESTMENTS, LP 02/14/2025 0 $0   -100.00% 0.00%
GSA CAPITAL PARTNERS LLP 02/07/2025 0 $0   -100.00% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 0 $0   -100.00% 0.00%
GROUND SWELL CAPITAL, LLC 02/14/2025 0 $0   -100.00% 0.00%
ALTIUM CAPITAL MANAGEMENT LP 02/13/2025 0 $0   -100.00% 0.00%
EMPOWER ADVISORY GROUP, LLC 01/31/2025 0 $0   -100.00% 0.00%
FULLCIRCLE WEALTH LLC 02/14/2025 0 $0   -100.00% 0.00%

Tempest Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 41 institutional investors and hedge funds held shares of Tempest Therapeutics, Inc.. The most heavily invested institutionals were:

Versant Venture Management, LLC: 3.51 M

BlackRock Funding, Inc. /DE: 551,861

JANE STREET GROUP, LLC: 493,094

FMR LLC: 431,932

GEODE CAPITAL MANAGEMENT, LLC: 354,276

UBS Group AG: 195,676

26.28% of Tempest Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 7.35 M shares in the last 24 months. This purchase volume represents approximately $6.99 M in transactions.